AKER News and Press, Akers Biosciences Inc. From 05/18/20

Thorofare, New Jersey, May 18, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced the closing of its previously announced registered direct offering of an aggregate of 1,366,856...

CytomX Stock Slumps on Disappointing Probody Data CytomX Therapeutics ( CTMX ) slumped as the company provided updates about its two lead drug candidates CX-072 and CX-2009. The company had also recently reported its financial results for the first quarter of 2020 and offered business upda...

Thorofare, New Jersey, May 14, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced that it has entered into definitive agreements with several institutional and accredited invest...

Gainers:  Applied DNA Sciences (NASDAQ: APDN ) +51% . More news on: Applied DNA Sciences, Inc., Akers Biosciences, Inc., Glory Star New Media Group Holdings Limited, Stocks on the move, , Read more ...

Nano cap Akers Biosciences ( AKER +31.2% ) bucks the broad market selloff on more than triple normal volume on its announcement that development partner Premas Biotech has completed a prototype of a COVID-19 vaccine. More news on: Akers Biosciences, Inc., Healthcare stocks news, Stocks...

Thorofare, New Jersey, May 14, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced that Premas Biotech, its partner in the development of a vaccine candidate that is seeking to a...

New York, New York--(Newsfile Corp. - April 24, 2020) - Akers Biosciences (NasdaqCM: AKER) announced a licensing agreement with Premas Biotech to find an effective vaccine for COVID-19. Premas Biotech has over 125 employees and has delivered over 650 proteins and has completed over 240 separ...

Mesoblast (NASDAQ: MESO ) +119%  as cell therapy shows significant benefit in COVID-19 patients. More news on: Mesoblast Limited, Medigus Ltd., Pluristem Therapeutics Inc., Stocks on the move, , Read more ...

These Penny Stocks Have Been Heading Higher This Week When it comes to penny stocks to buy , the typical path of making money is to buy low and sell high. Unlike higher-priced stocks, stocks trading under $4 can move much more quickly. So while some people will look for new and other event-dr...

Source: marketbeat In March, the obscure biotech company Akers Biosciences (AKER) became known to a larger number of investors on the news it had entered into a licensing deal with Premas Biotech to work together on developing a vaccine to treat COVID-19, including Akers' expertise in ...